Literature DB >> 1965793

Autoimmune pancytopenia following allogeneic bone marrow transplantation.

T R Klumpp1, M A Caligiuri, S N Rabinowe, R J Soiffer, C Murray, J Ritz, M A Caliguri.   

Abstract

A 47-year-old female developed autoimmune hemolytic anemia, autoimmune neutropenia, and autoimmune thrombocytopenia 19 months following allogeneic bone marrow transplantation for chronic myelogenous leukemia. Treatment with high-dose corticosteroids resulted in marked improvement in all three cell lines.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1965793

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  4 in total

1.  Anti-CD20 monoclonal antibody therapy for autoimmune hemolytic anemia following T cell-depleted, haplo-identical stem cell transplantation.

Authors:  A Ship; W May; K Lucas
Journal:  Bone Marrow Transplant       Date:  2002-02       Impact factor: 5.483

2.  Successful matched unrelated transplantation from a donor with idiopathic thrombocytopenic purpura (ITP).

Authors:  M Delukina; Y Kapelushnik; R Or; E Naparstek; S Slavin; A Nagler
Journal:  Med Oncol       Date:  1995-06       Impact factor: 3.064

Review 3.  Successful treatment of severe immune hemolytic anemia after allogeneic stem cell transplantation with bortezomib: report of a case and review of literature.

Authors:  Sakura Hosoba; David L Jaye; Cynthia Cohen; John D Roback; Edmund K Waller
Journal:  Transfusion       Date:  2014-08-25       Impact factor: 3.157

Review 4.  Autoimmune Hemolytic Anemia in Chronic Myeloid Leukemia.

Authors:  Tahseen Hamamyh; Mohamed A Yassin
Journal:  Pharmacology       Date:  2020-06-02       Impact factor: 2.547
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.